Medication review and reconciliation with cooperation between pharmacist and general practitioner and the benefit for the patient: A systematic review

British Journal of Clinical Pharmacology

Volumn 74, Issue 1, 2012, Pages 16-33

  Geurts, Marlies M E ^a   Talsma, Jaap ^b   Brouwers, Jacobus R B J ^a   de Gier, Johan J ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Family physician; Interprofessional relations; Patient care; Pharmaceutical care; Pharmaceutical services; Pharmacist

Indexed keywords

ARTICLE; GENERAL PRACTITIONER; HEALTH; HOSPITAL READMISSION; HUMAN; INTERVIEW; MEDICAL EDUCATION; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT COMPLIANCE; PHARMACIST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REIMBURSEMENT; SYSTEMATIC REVIEW; TEAMWORK;

GENERAL PRACTITIONERS; HUMANS; PATIENT CARE; PHARMACISTS; PRACTICE GUIDELINES AS TOPIC; PRESCRIPTION DRUGS; QUALITY OF HEALTH CARE;

EID: 84862138510     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2012.04178.x     Document Type: Article

References (99)

1. FIP Working Group on Collaborative Practice. FIP Reference Paper Collaborative Practice. 2009. Available at (last accessed 12 October 2011).
2. Gillespie U, Alassaad A, Henrohn D, Garmo H, Hammarlund-Udenaes M, Toss H etal. A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial. Arch Intern Med 2009; 169: 894-900.
3. Michie S, Miles J, Weinman J. Patient-centredness in chronic illness: what is it and does it matter? Patient Educ Couns 2003; 51: 197-206.
4. Holman H, Lorig K. Patients as partners in managing chronic disease. Partnership is a prerequisite for effective and efficient health care. BMJ 2000; 320: 526-7.
5. Cipolle RJ, Strand LM, Morley PC. In: Pharmaceutical Care Practice The Clinician's Guide, 2nd edn. New York, NY: The McGraw-Hill Companies, Inc., 2004.
6. Task Force on Medicines Partnership and The National Collaborative Medicines Management, Services Programme. Room for Review: A guide to medication review: the agenda for patients, practitioners and managers. 2002. Available at (last accessed 12 October 2011).
7. Karapinar-Carkit F, Borgsteede SD, Zoer J, Smit HJ, Egberts AC, van den Bemt PM. Effect of medication reconciliation with and without patient counseling on the number of pharmaceutical interventions among patients discharged from the hospital. Ann Pharmacother 2009; 43: 1001-10.
8. Medicines PP. A Guide to Medication Review 2008. 2008. Available at (last 12 accessed October 2011).
9. Farris KB, Cote I, Feeny D, Johnson JA, Tsuyuki RT, Brilliant S etal. Enhancing primary care for complex patients. Demonstration project using multidisciplinary teams. Can Fam Physician 2004; 50: 998-1003.
10. Graffen M, Kennedy D, Simpson M. Quality use of medicines in the rural ambulant elderly: a pilot study. Rural Remote Health 2004; 4: 184.
11. Holland R, Lenaghan E, Harvey I, Smith R, Shepstone L, Lipp A etal. Does home based medication review keep older people out of hospital? The HOMER randomised controlled trial. BMJ 2005; 330: 293.
12. Leendertse AJ. Hospital Admissions Related to Medication. Prevalence, Provocation and Prevention. Utrecht: Utrecht University, 2010.
13. Lenaghan E, Holland R, Brooks A. Home-based medication review in a high risk elderly population in primary care - the POLYMED randomised controlled trial. Age Ageing 2007; 36: 292-7.
14. Makowsky MJ, Koshman SL, Midodzi WK, Tsuyuki RT. Capturing outcomes of clinical activities performed by a rounding pharmacist practicing in a team environment: the COLLABORATE study [NCT00351676]. Med Care 2009; 47: 642-50.
15. Nazareth I, Burton A, Shulman S, Smith P, Haines A, Timberal H. A pharmacy discharge plan for hospitalized elderly patients - a randomized controlled trial. Age Ageing 2001; 30: 33-40.
16. Roughead EE, Barratt JD, Ramsay E, Pratt N, Ryan P, Peck R etal. The effectiveness of collaborative medicine reviews in delaying time to next hospitalization for patients with heart failure in the practice setting: results of a cohort study. Circ Heart Fail 2009; 2: 424-8.
17. Roughead EE, Barratt JD, Ramsay E, Pratt N, Ryan P, Peck R etal. Collaborative home medicines review delays time to next hospitalization for warfarin associated bleeding in Australian war veterans. J Clin Pharm Ther 2011; 36: 27-32.
18. Nkansah N, Mostovetsky O, Yu C, Chheng T, Beney J, Bond CM etal. Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns. Cochrane Database Syst Rev 2010; (7): CD000336.
19. Denneboom W, Dautzenberg MG, Grol R, De Smet PA. Treatment reviews of older people on polypharmacy in primary care: cluster controlled trial comparing two approaches. Br J Gen Pract 2007; 57: 723-31.
20. Charles C, Whelan T, Gafni A. What do we mean by partnership in making decisions about treatment? BMJ 1999; 319: 780-2.
21. Jordan JL, Ellis SJ, Chambers R. Defining shared decision making and concordance: are they one and the same? Postgrad Med J 2002; 78: 383-4.
22. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005; 353: 487-97.
23. Isetts BJ, Brown LM, Schondelmeyer SW, Lenarz LA. Quality assessment of a collaborative approach for decreasing drug-related morbidity and achieving therapeutic goals. Arch Intern Med 2003; 163: 1813-20.
24. Warlé-van Herwaarden M, Kramers C, Sturkenboom M, Van den Bemt PMLA, De Smet PAGM. Targeting outpatient drug safety: recommendations of the Dutch HARM-Wrestling task force. 2011. Available at (last accessed 12 October 2011).
25. De Smet PA. Hospital admissions related to medications and implementing guidelines. Arch Intern Med 2009; 169: 810-1.
26. Perez A, Doloresco F, Hoffman JM, Meek PD, Touchette DR, Vermeulen LC etal. ACCP: economic evaluations of clinical pharmacy services: 2001-2005. Pharmacotherapy 2008; 28: 285e-323e.
27. Bell JS, Whitehead P, Aslani P, McLachlan AJ, Chen TF. Drug-related problems in the community setting: pharmacists' findings and recommendations for people with mental illnesses. Clin Drug Investig 2006; 26: 415-25.
28. Bereznicki BJ, Peterson GM, Jackson SL, Walters H, Fitzmaurice K, Gee P. Pharmacist-initiated general practitioner referral of patients with suboptimal asthma management. Pharm World Sci 2008; 30: 869-75.
29. Bereznicki B, Peterson G, Jackson S, Walters EH, Gee P. The sustainability of a community pharmacy intervention to improve the quality use of asthma medication. J Clin Pharm Ther 2011; 36: 144-51.
30. Blenkinsopp A, Jepson M, Drury M. Using a notification card to improve communication between community pharmacists and general practitioners. Br J Gen Pract 1991; 41: 116-8.
31. Bond CM, Fish A, Porteous TH, Reid JP, Scott A, Antonazzo E. A randomised controlled trial of the effects of note-based medication review by community pharmacists on prescribing of cardiovascular drugs in general practice. Int J Pharm Pract 2007; 15: 39-46.
32. Bonner CJ, Carr B. Medication compliance problems in general practice: detection and intervention by pharmacists and doctors. Aust J Rural Health 2002; 10: 33-8.
33. Brulhart MI, Wermeille JP. Multidisciplinary medication review: evaluation of a pharmaceutical care model for nursing homes. Int J Clin Pharm 2011; 33: 549-57.
34. Bryant LJM, Coster G, Gamble GD, McCormick RN. The General Practitioner-Pharmacist Collaboration (GPPC) study: a randomised controlled trial of clinical medication reviews in community pharmacy. Int J Pharm Pract 2011; 19: 94-105.
35. Capoccia KL, Boudreau DM, Blough DK, Ellsworth AJ, Clark DR, Stevens NG etal. Randomized trial of pharmacist interventions to improve depression care and outcomes in primary care. Am J Health Syst Pharm 2004; 61: 364-72.
36. Boudreau DM, Capoccia KL, Sullivan SD, Blough DK, Ellsworth AJ, Clark DL etal. Collaborative care model to improve outcomes in major depression. Ann Pharmacother 2002; 36: 585-91.
37. Carter BL, Ardery G, Dawson JD, James PA, Bergus GR, Doucette WR etal. Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med 2009; 169: 1996-2002.
38. Castelino RL, Bajorek BV, Chen TF. Retrospective evaluation of home medicines review by pharmacists in older Australian patients using the medication appropriateness index. Ann Pharmacother 2010; 44: 1922-9.
39. Castelino RL, Bajorek BV, Chen TF. Are interventions recommended by pharmacists during Home Medicines Review evidence-based? J Eval Clin Pract 2011; 17: 104-10.
40. Chambers LW, Kaczorowski J, Dolovich L, Karwalajtys T, Hall HL, McDonough B etal. A community-based program for cardiovascular health awareness. Can J Public Health 2005; 96: 294-8.
41. Chen J, Britten N. 'Strong medicine': an analysis of pharmacist consultations in primary care. Fam Pract 2000; 17: 480-3.
42. Coleman DJ, Portlock J, Brown D. Delivering domiciliary pharmaceutical care from a health centre pharmacy. Int J Pharm Pract 2001; 9: 127-37.
43. Community Pharmacy Medicines Management Project Evaluation Team. The MEDMAN study: a randomized controlled trial of community pharmacy-led medicines management for patients with coronary heart disease. Fam Pract 2007; 24: 189-200.
44. Crotty M, Halbert J, Rowett D, Giles L, Birks R, Williams H etal. An outreach geriatric medication advisory service in residential aged care: a randomised controlled trial of case conferencing. Age Ageing 2004; 33: 612-7.
45. Dolovich L, Pottie K, Kaczorowski J, Farrell B, Austin Z, Rodriguez C etal. Integrating family medicine and pharmacy to advance primary care therapeutics. Clin Pharmacol Ther 2008; 83: 913-7.
46. Doucette WR, McDonough RP, Klepser D, McCarthy R. Comprehensive medication therapy management: identifying and resolving drug-related issues in a community pharmacy. Clin Ther 2005; 27: 1104-11.
47. Earle KA, Taylor P, Wyatt S, Burnett S, Ray J. A physician-pharmacist model for the surveillance of blood pressure in the community: a feasibility study. J Hum Hypertens 2001; 15: 529-33.
48. Fejzic JB, Tett SE. Medication management reviews for people from the former Yugoslavia now resident in Australia. Pharm World Sci 2004; 26: 271-6.
49. Fiss T, Ritter CA, Alte D, van den Berg N, Hoffmann W. Detection of drug related problems in an interdisciplinary health care model for rural areas in Germany. Pharm World Sci 2010; 32: 566-74.
50. Forstrom MJ, Ried LD, Stergachis AS, Corliss DA. Effect of a clinical pharmacist program on the cost of hypertension treatment in an HMO family practice clinic. DICP 1990; 24: 304-9.
51. Gilbert AL, Roughead EE, Beilby J, Mott K, Barratt JD. Collaborative medication management services: improving patient care. Med J Aust 2002; 177: 189-92.
52. Goldstein R, Hulme H, Willits J. Reviewing repeat prescribing - general practitioners and community pharmacists working together. Int J Pharm Pract 1998; 6: 60-6.
53. Harris IM, Westberg SM, Frakes MJ, Van Vooren JS. Outcomes of medication therapy review in a family medicine clinic. J Am Pharm Assoc 2009; 49: 623-7.
54. Haxby DG, Weart CW, Goodman BW Jr. Family practice physicians' perceptions of the usefulness of drug therapy recommendations from clinical pharmacists. Am J Hosp Pharm 1988; 45: 824-7.
55. Hellstrom LM, Bondesson A, Hoglund P, Midlov P, Holmdahl L, Rickhag E etal. Impact of the Lund Integrated Medicines Management (LIMM) model on medication appropriateness and drug-related hospital revisits. Eur J Clin Pharmacol 2011; 67: 741-52.
56. Pacini M, Smith RD, Wilson EC, Holland R. Home-based medication review in older people: is it cost effective? Pharmacoeconomics 2007; 25: 171-80.
57. Hourihan F, Krass I, Chen T. Rural community pharmacy: a feasible site for a health promotion and screening service for cardiovascular risk factors. Aust J Rural Health 2003; 11: 28-35.
58. Jameson J, VanNoord G, Vanderwoud K. The impact of a pharmacotherapy consultation on the cost and outcome of medical therapy. J Fam Pract 1995; 41: 469-72.
59. Jamieson LH, Scally AJ, Chrystyn H. A randomised comparison of practice pharmacist-managed hypertension providing Level 3 Medication Review versus usual care in general practice. J Appl Ther Res 2010; 7: 77-86.
60. Kiel PJ, McCord AD. Pharmacist impact on clinical outcomes in a diabetes disease management program via collaborative practice. Ann Pharmacother 2005; 39: 1828-32.
61. King MA, Roberts MS. Multidisciplinary case conference reviews: improving outcomes for nursing home residents, carers and health professionals. Pharm World Sci 2001; 23: 41-5.
62. Krska J, Cromarty JA, Arris F, Jamieson D, Hansford D, Duffus PR etal. Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing 2001; 30: 205-11.
63. Kwint HF, Luchtman T, Krijger-Dijkema JM, Eekhof J, De Kanter J. Physician and pharmacist monitor together. Monitoring of repeat prescriptions for drug-related problems. Pharm Weekbl 2003; 138: 1732-7.
64. Kwint HF, Faber A, Gussekloo J, Bouvy ML. Effects of medication review on drug-related problems in patients using automated drug-dispensing systems: a pragmatic randomized controlled study. Drugs Aging 2011; 28: 305-14.
65. Lobas NH, Lepinski PW, Abramowitz PW. Effects of pharmaceutical care on medication cost and quality of patient care in an ambulatory-care clinic. Am J Hosp Pharm 1992; 49: 1681-8.
66. Lowe CJ, Raynor DK, Purvis J, Farrin A, Hudson J. Effects of a medicine review and education programme for older people in general practice. Br J Clin Pharmacol 2000; 50: 172-5.
67. Mangiapane S, Schulz M, Muhlig S, Ihle P, Schubert I, Waldmann HC. Community pharmacy-based pharmaceutical care for asthma patients. Ann Pharmacother 2005; 39: 1817-22.
68. McDermott ME, Smith BH, Elliott AM, Bond CM, Hannaford PC, Chambers WA. The use of medication for chronic pain in primary care, and the potential for intervention by a practice-based pharmacist. Fam Pract 2006; 23: 46-52.
69. Needham DS, Wong IC, Campion PD, Hull and East Riding Pharmacy Developmnet Group. Evaluation of the effectiveness of UK community pharmacists' interventions in community palliative care. Palliat Med 2002; 16: 219-25.
70. Nishtala PS, Hilmer SN, McLachlan AJ, Hannan PJ, Chen TF. Impact of residential medication management reviews on drug burden index in aged-care homes: a retrospective analysis. Drugs Aging 2009; 26: 677-86.
71. Nishtala PS, McLachlan AJ, Bell JS, Chen TF. A retrospective study of drug-related problems in Australian aged care homes: medication reviews involving pharmacists and general practitioners. J Eval Clin Pract 2011; 17: 97-103.
72. Niquille A, Bugnon O. Relationship between drug-related problems and health outcomes: a cross-sectional study among cardiovascular patients. Pharm World Sci 2010; 32: 512-9.
73. Patterson SM, Hughes CM, Crealey G, Cardwell C, Lapane KL. An evaluation of an adapted U.S. model of pharmaceutical care to improve psychoactive prescribing for nursing home residents in northern ireland (fleetwood northern ireland study). J Am Geriatr Soc 2010; 58: 44-53.
74. Patterson SM, Hughes CM, Cardwell C, Lapane KL, Murray AM, Crealey GE. A cluster randomized controlled trial of an adapted U.S. model of pharmaceutical care for nursing home residents in Northern Ireland (Fleetwood Northern Ireland study): a cost-effectiveness analysis. J Am Geriatr Soc 2011; 59: 586-93.
75. Phelan M, Blenkinsopp A, Foster NE, Thomas E, Hay EM. Pharmacist-led medication review for knee pain in older adults: Content, process and outcomes. Int J Pharm Pract 2008; 16: 347-55.
76. Raynor DK, Nicolson M, Nunney J, Petty D, Vail A, Davies L. The development and evaluation of an extended adherence support programme by community pharmacists for elderly patients at home. Int J Pharm Pract 2000; 8: 157-64.
77. RESPECT trial team. Effectiveness of shared pharmaceutical care for older patients: RESPECT trial findings. Br J Gen Pract 2010; 60: e10-9.
78. Ryan-Woolley BM, Cantrill JA. Professional perspective on a feasibility study of GP-pharmacist collaboration in the management of angina. Int J Pharm Pract 2000; 8: 275-84.
79. Schmidt I, Claesson CB, Westerholm B, Nilsson LG, Svarstad BL. The impact of regular multidisciplinary team interventions on psychotropic prescribing in Swedish nursing homes. J Am Geriatr Soc 1998; 46: 77-82.
80. Schneider J, Barber N. Provision of a domiciliary service by community pharmacists. Int J Pharm Pract 1996; 4: 19-24.
81. Schulz M, Verheyen F, Muhlig S, Muller JM, Muhlbauer K, Knop-Schneickert E etal. Pharmaceutical care services for asthma patients: a controlled intervention study. J Clin Pharmacol 2001; 41: 668-76.
82. Sellors J, Sellors C, Woodward C, Dolovich L, Poston J, Trim K etal. Expanded role pharmacists: Consulting in family physicians' offices - a highly acceptable program model. Can Pharm J 2001; 134: 27-31.
83. Sellors J, Kaczorowski J, Sellors C, Dolovich L, Woodward C, Willan A etal. A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients. CMAJ 2003; 169: 17-22.
84. Shimp LA, Glazer HM, Reinke CM, Ascione FJ, Peggs JF, Reinhardt RW. A systematic approach to identifying and reducing medication-related problems in family practice patients. Fam Pract Res J 1986; 5: 247-54.
85. Soendergaard B, Kirkeby B, Dinsen C, Herborg H, Kjellberg J, Staehr P. Drug-related problems in general practice: results from a development project in Denmark. Pharm World Sci 2006; 28: 61-4.
86. Sorensen L, Stokes JA, Purdie DM, Woodward M, Elliott R, Roberts MS. Medication reviews in the community: results of a randomized, controlled effectiveness trial. Br J Clin Pharmacol 2004; 58: 648-64.
87. Stafford L, Stafford A, Hughes J, Angley M, Bereznicki L, Peterson G. Drug-related problems identified in post-discharge medication reviews for patients taking warfarin. Int J Clin Pharm 2011; 33: 621-6.
88. Stafford L, Peterson GM, Bereznicki LR, Jackson SL, van Tienen EC, Angley MT etal. Clinical outcomes of a collaborative, home-based postdischarge warfarin management service. Ann Pharmacother 2011; 45: 325-34.
89. Stergachis A, Fors M, Wagner EH, Sims DD, Penna P. Effect of clinical pharmacists on drug prescribing in a primary-care clinic. Am J Hosp Pharm 1987; 44: 525-9.
90. Stuijt CCM, Franssen EJF, Egberts ACG, Hudson SA. Appropriateness of prescribing among elderly patients in a Dutch residential home: observational study of outcomes after a pharmacist-led medication review. Drugs Aging 2008; 25: 947-54.
91. Towle I, Adams J. A novel, pharmacist-led strategy to reduce the prescribing of benzodiazepines in Paisley. Pharm J 2006; 276: 136-8.
92. Villeneuve J, Genest J, Blais L, Vanier MC, Lamarre D, Fredette M etal. A cluster randomized controlled Trial to Evaluate an Ambulatory primary care Management program for patients with dyslipidemia: the TEAM study. CMAJ 2010; 182: 447-55.
93. Vinks THAM, Egberts TCG, de Lange TM, de Koning FHP. Pharmacist-based medication review reduces potential drug-related problems in the elderly: the SMOG controlled trial. Drugs Aging 2009; 26: 123-33.
94. Wermeille J, Bennie M, Brown I, McKnight J. Pharmaceutical care model for patients with type 2 diabetes: integration of the community pharmacist into the diabetes team - a pilot study. Pharm World Sci 2004; 26: 18-25.
95. Wilcock M, Harding G. What do pharmacists think of MURs and do they change prescribed medication? Pharm J 2008; 281: 163-7.
96. Wong C, Cave A, Jarman R. Pharmaceutical care in a family medicine centre. Can Pharm J 1997; 130: 35-43.
97. Yu K, Nguyen A, Shakib S, Doecke CJ, Boyce M, March G etal. Enhancing continuity of care in therapeutics: Development of a post-discharge home medicines review model. J Pharm Pract Res 2007; 37: 22-6.
98. Zermansky AG, Petty DR, Raynor DK, Freemantle N, Vail A, Lowe CJ. Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. BMJ 2001; 323: 1340-3.
99. Zermansky AG, Alldred DP, Petty DR, Raynor DK, Freemantle N, Eastaugh J etal. Clinical medication review by a pharmacist of elderly people living in care homes - randomised controlled trial. Age Ageing 2006; 35: 586-91.